Mostrar el registro sencillo del ítem

dc.contributor.authorReigada-Rivera, María Luisa
dc.contributor.authorSanz Lozano, Catalina Sofía 
dc.contributor.authorMoreno Rodilla, Esther María 
dc.contributor.authorGarcía Sánchez, María Asunción 
dc.contributor.authorGarcía-Solaesa, Virginia
dc.contributor.authorLorente Toledano, Félix
dc.contributor.authorDávila González, Ignacio Jesús 
dc.contributor.authorIsidoro García, María 
dc.date.accessioned2024-06-27T11:17:56Z
dc.date.available2024-06-27T11:17:56Z
dc.date.issued2022-03-28
dc.identifier.citationReigada-Rivera, M. L., Lozano, C. S., Rodilla, E. M., García-Sánchez, A., García-Solaesa, V., Toledano, F. L., González, I. D., & Isidoro-García, M. (2022). Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease. Genes, 13(4). https://doi.org/10.3390/GENES13040605. PMID: 35456412; PMCID: PMC9031626.es_ES
dc.identifier.urihttp://hdl.handle.net/10366/158669
dc.description.abstract[EN]Background: The role of genetics in non-steroidal anti-inflammatory drugs (NSAID) exacerbated respiratory disease (NERD) is unclear, with different candidates involved, such as HLA genes, genes related to leukotriene synthesis, and cytokine genes. This study aimed to determine possible associations between 22 polymorphisms in 13 cytokine genes. Methods: We included 195 patients (85 with NERD and 110 with respiratory disease who tolerate NSAIDs) and 156 controls (non-atopic individuals without a history of asthma, nasal polyposis (NP), or NSAID hypersensitivity). Genotyping was performed by sequence-specific primer polymerase chain reaction (PCR-SSP). Amplicons were analyzed by horizontal gel electrophoresis in 2% agarose. Results: Significant differences in allele and genotype frequency distributions were found in TNF (rs1800629), IL4 (rs2243248 and rs2243250), and IL10 (rs1800896, rs1800871, and rs1800872) genes in patients with NSAID hypersensitivity. In all cases, the minor allele and the heterozygous genotype were more prevalent in NERD. An association of TNF rs1800629 SNP with respiratory disease in NSAID-tolerant patients was also found. Conclusions: Retrospectively recorded, we found strong associations of NERD with polymorphisms in IL4, IL10, and TNF genes, suggesting that these genes could be involved in the inflammatory mechanisms underlying NERD.en_EN
dc.description.sponsorshipSociedad Española de Alergología e Inmunología Clínica; Fundación de Investigación Médica Caja de Burgos; Instituto de Salud Carlos III’s Thematic Network of Cooperative Research in Health-RETICS (Thematic network of research in health Asthma, Adverse and Allergic Reactions, ARADYAL),es_ES
dc.language.isoenges_ES
dc.publisherMDPIen_EN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectNERDen_EN
dc.subjectNSAID hypersensitivityen_EN
dc.subjectAsthmaen_EN
dc.subjectNasal polyposisen_EN
dc.subjectPolymorphismen_EN
dc.subject.meshGenetics *
dc.subject.meshAllergy and Immunology *
dc.titlePolymorphisms in human IL4, IL10, and TNF genes are associated with an increased risk of developing NSAID-exacerbated respiratory diseaseen_EN
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.3390/genes13040605es_ES
dc.subject.unesco3207.01 Alergiases_ES
dc.subject.unesco2409 Genéticaes_ES
dc.identifier.doi10.3390/genes13040605
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid35456412
dc.identifier.essn2073-4425
dc.journal.titleGenesen_EN
dc.volume.number13es_ES
dc.issue.number4es_ES
dc.page.initial605es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsalergia e inmunología *
dc.subject.decsgenética *


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional